Table 2

Summary of disease and stage risk groups

Risk
Disease  
    AML-favorable cytogenetics Low 
    CLL Low 
    CML Low 
    Indolent B-cell NHL Low 
    ALL Intermediate 
    AML intermediate cytogenetics Intermediate 
    MDS intermediate cytogenetics Intermediate 
    Myeloproliferative neoplasms Intermediate 
    Multiple Myeloma Intermediate 
    Hodgkin lymphoma Intermediate 
    DLBCL/Transformed indolent B-NHL Intermediate 
    Mantle cell lymphoma Intermediate 
    T-cell lymphoma, nodal Intermediate 
    AML adverse cytogenetics High 
    MDS adverse cytogenetics High 
    T-cell lymphoma, extranodal High 
Stage  
    1st CR Low 
    2nd or subsequent CR Low 
    1st PR Low 
    Untreated Low 
    Chronic-phase CML Low 
    2nd or subsequent PR (if RIC) Low 
    2nd or subsequent PR (if MAC) High 
    Induction failure High 
    Active relapse High 
    Accelerated or blast-phase CML High 
Risk
Disease  
    AML-favorable cytogenetics Low 
    CLL Low 
    CML Low 
    Indolent B-cell NHL Low 
    ALL Intermediate 
    AML intermediate cytogenetics Intermediate 
    MDS intermediate cytogenetics Intermediate 
    Myeloproliferative neoplasms Intermediate 
    Multiple Myeloma Intermediate 
    Hodgkin lymphoma Intermediate 
    DLBCL/Transformed indolent B-NHL Intermediate 
    Mantle cell lymphoma Intermediate 
    T-cell lymphoma, nodal Intermediate 
    AML adverse cytogenetics High 
    MDS adverse cytogenetics High 
    T-cell lymphoma, extranodal High 
Stage  
    1st CR Low 
    2nd or subsequent CR Low 
    1st PR Low 
    Untreated Low 
    Chronic-phase CML Low 
    2nd or subsequent PR (if RIC) Low 
    2nd or subsequent PR (if MAC) High 
    Induction failure High 
    Active relapse High 
    Accelerated or blast-phase CML High 

ALL indicates acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myelogenous leukemia; CR, complete remission; DLBCL, diffuse large B-cell lymphoma; MAC, myeloablative conditioning; MDS, myelodysplastic syndrome; NHL, non-Hodgkin lymphoma; PR, partial remission; and RIC, reduced-intensity conditioning.

Close Modal

or Create an Account

Close Modal
Close Modal